Literature DB >> 2907797

Accidental X-Y recombination and the aetiology of XX males and true hermaphrodites.

M A Ferguson-Smith1, N A Affara.   

Abstract

Accidental recombination between the differential segments of the X and Y chromosomes in man occasionally allows transfer of Y-linked sequences to the X chromosome leading to testis differentiation in so-called XX males. Loss of the same sequences by X-Y interchange allows female differentiation in a small proportion of individuals with XY gonadal dysgenesis. A candidate gene responsible for primary sex determination has recently been cloned from within this part of the Y chromosome by Page and his colleagues. The observation that a homologue of this gene is present on the short arm of the X chromosome and is subject to X-inactivation, raises the intriguing possibility that sex determination in man is a quantitative trait. Males have two active doses of the gonad determining gene, and females have one dose. This hypothesis has been tested in a series of XX males, XY females and XX true hermaphrodites by using a genomic probe, CMPXY1, obtained by probing a Y-specific DNA library with synthetic oligonucleotides based on the predicted amino-acid sequence of the sex-determining protein. The findings in most cases are consistent with the hypothesis of homologous gonad-determining genes, GDX and GDY, carried by the X and Y chromosomes respectively. It is postulated that in sporadic or familial XX true hermaphrodites one of the GDX loci escapes X-inactivation because of mutation or chromosomal rearrangement, resulting in mosaicism for testis and ovary-determining cell lines in somatic cells. Y-negative XX males belong to the same clinical spectrum as XX true hermaphrodites, and gonadal dysgenesis in some XY females may be due to sporadic or familial mutations of GDX.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2907797     DOI: 10.1098/rstb.1988.0121

Source DB:  PubMed          Journal:  Philos Trans R Soc Lond B Biol Sci        ISSN: 0962-8436            Impact factor:   6.237


  7 in total

1.  Comparison of ZFY and ZFX gene structure and analysis of alternative 3' untranslated regions of ZFY.

Authors:  M North; C Sargent; J O'Brien; K Taylor; J Wolfe; N A Affara; M A Ferguson-Smith
Journal:  Nucleic Acids Res       Date:  1991-05-25       Impact factor: 16.971

2.  Genotype-phenotype correlations in XX males and their bearing on current theories of sex determination.

Authors:  M A Ferguson-Smith; A Cooke; N A Affara; E Boyd; J L Tolmie
Journal:  Hum Genet       Date:  1990-01       Impact factor: 4.132

3.  Molecular, cytogenetic, and clinical characterisation of six XX males including one prenatal diagnosis.

Authors:  E Margarit; A Soler; A Carrió; R Oliva; D Costa; T Vendrell; J Rosell; F Ballesta
Journal:  J Med Genet       Date:  1998-09       Impact factor: 6.318

4.  Evidence for distinguishable transcripts of the putative testis determining gene (ZFY) and mapping of homologous cDNA sequences to chromosomes X,Y and 9.

Authors:  N A Affara; D Chambers; J O'Brien; S S Habeebu; M Kalaitsidaki; C E Bishop; M A Ferguson-Smith
Journal:  Nucleic Acids Res       Date:  1989-04-25       Impact factor: 16.971

Review 5.  Abnormalities of human sex determination.

Authors:  M A Ferguson-Smith
Journal:  J Inherit Metab Dis       Date:  1992       Impact factor: 4.982

6.  A possible common origin of "Y-negative" human XX males and XX true hermaphrodites.

Authors:  N E Abbas; J E Toublanc; C Boucekkine; M Toublanc; N A Affara; J C Job; M Fellous
Journal:  Hum Genet       Date:  1990-03       Impact factor: 4.132

7.  Unique case reports associated with ovarian failure: necessity of two intact x chromosomes.

Authors:  Lakshmi Rao Kandukuri; Venkata Padmalatha; Murthy Kanakavalli; Raseswari Turlapati; Mangalipally Swapna; Metuku Vidyadhari; Govindaraghavan Saranaya; Kattera Himaja; Mamata Deenadayal; Bipin Kumar Sethi; Prasun Deb; Nalini Gupta; Baidyanath Chakraborthy; Pratibha Nallari; Lalji Singh
Journal:  Case Rep Genet       Date:  2012-04-11
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.